Anti-ENT1 抗体 (ab48607)

ab48607 は 7 報の論文で使用されています。

• Osgood CL  et al. (18)F-FLT Positron Emission Tomography (PET) is a Pharmacodynamic Marker for EWS-FLI1 Activity and Ewing Sarcoma. Sci Rep 6:33926 (2016). PubMed: 27671553
• Bicket A  et al. Novel regulation of equlibrative nucleoside transporter 1 (ENT1) by receptor-stimulated Ca2+-dependent calmodulin binding. Am J Physiol Cell Physiol 310:C808-20 (2016). PubMed: 27009875
• Kerr M  et al. Deoxycytidine kinase expression underpins response to gemcitabine in bladder cancer. Clin Cancer Res 20:5435-45 (2014). PubMed: 25224279
• Eckle T  et al. Crosstalk between the equilibrative nucleoside transporter ENT2 and alveolar Adora2b adenosine receptors dampens acute lung injury. FASEB J 27:3078-89 (2013). PubMed: 23603835
• Shan D  et al. Expression of equilibrative nucleoside transporter type 1 protein in elderly patients with schizophrenia. Neuroreport 23:224-7 (2012). WB ; Human . PubMed: 22314683
• Takano M  et al. Human erythrocyte nucleoside transporter ENT1 functions at ice-cold temperatures. Drug Metab Pharmacokinet 25:351-60 (2010). WB ; Human . PubMed: 20814156
• Plotnik DA  et al. Different modes of transport for 3H-thymidine, 3H-FLT, and 3H-FMAU in proliferating and nonproliferating human tumor cells. J Nucl Med 51:1464-71 (2010). PubMed: 20720049